Cassava Financial Statements From 2010 to 2026

Stocks . USA . 
Stock . Cassava Sciences
SAVA Stock  USD 2.14  0.04  1.83%   
Cassava Sciences' financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Cassava Sciences' valuation are provided below:
Gross Profit
-57 M
Market Capitalization
142 M
Earnings Share
(2.22)
We have found one hundred twenty available fundamental signals for Cassava Sciences, which can be analyzed and compared to other ratios and to its rivals. All investors should make sure to validate all of Cassava Sciences prevailing market performance against the performance between 2010 and 2026 to make sure the company can sustain itself down the road. As of January 8, 2026, Market Cap is expected to decline to about 27.8 M. The current year's Enterprise Value is expected to grow to about (74 M)

Cassava Sciences Total Revenue

(1,800)

Check Cassava Sciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Cassava Sciences' main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.4 M, Interest Expense of 4.6 M or Total Revenue of 0.0, as well as many indicators such as Price To Sales Ratio of 0.83, Dividend Yield of 2.21 or PTB Ratio of 0.82. Cassava financial statements analysis is a perfect complement when working with Cassava Sciences Valuation or Volatility modules.
  
Build AI portfolio with Cassava Stock
Check out the analysis of Cassava Sciences Correlation against competitors.
For information on how to trade Cassava Stock refer to our How to Trade Cassava Stock guide.

Cassava Sciences Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets116.7 M181.2 M92.1 M
Slightly volatile
Total Current Liabilities7.4 M10.6 M5.8 M
Slightly volatile
Total Stockholder Equity175.9 M167.6 M85.6 M
Slightly volatile
Property Plant And Equipment Net25.3 M24.1 M8.1 M
Slightly volatile
Accounts Payable9.2 M8.8 M3.1 M
Slightly volatile
Cash155.3 M147.9 M83.1 M
Slightly volatile
Non Current Assets Total25.4 M24.2 M8.3 M
Slightly volatile
Cash And Short Term Investments102.5 M147.9 M81.5 M
Slightly volatile
Net Receivables809.7 K852.3 K885.7 K
Slightly volatile
Common Stock Total Equity39.3 K46 K35.8 K
Pretty Stable
Common Stock Shares Outstanding56.3 M53.6 M25 M
Slightly volatile
Liabilities And Stockholders Equity116.7 M181.2 M92.1 M
Slightly volatile
Other Current Assets8.5 M8.1 M3.3 M
Slightly volatile
Other Stockholder Equity665.1 M633.4 M300.9 M
Slightly volatile
Total Liabilities10.1 M10.6 M10.4 M
Pretty Stable
Property Plant And Equipment Gross29.2 M27.8 M8.9 M
Slightly volatile
Total Current Assets111.9 M157 M85 M
Slightly volatile
Common Stock40.4 K55.2 K37.1 K
Pretty Stable
Other Current Liabilities2.5 M4.7 M2 M
Slightly volatile
Current Deferred Revenue4 M4.2 M4.6 M
Slightly volatile
Short Term Debt88.9 K93.6 K577.2 K
Slightly volatile
Net Tangible Assets274 M261 M108.9 M
Slightly volatile
Capital Surpluse556.9 M530.4 M286.8 M
Slightly volatile
Deferred Long Term Liabilities30 M30.4 M34.2 M
Slightly volatile
Property Plant Equipment27.8 M26.4 M8.6 M
Slightly volatile
Net Invested Capital124.9 M167.6 M74.6 M
Slightly volatile
Net Working Capital112.7 M143.5 M67.2 M
Slightly volatile
Capital Stock38.7 K55.2 K28 K
Slightly volatile
Short and Long Term Debt Total208.4 K159.8 K130.3 K
Slightly volatile
Non Current Liabilities Other141 K71.1 K196.8 K
Slightly volatile
Other Liabilities215.1 K226.6 K197.7 K
Slightly volatile
Intangible Assets31.6 K33.3 K811.8 K
Slightly volatile

Cassava Sciences Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization1.4 M1.3 M554.8 K
Slightly volatile
Other Operating Expenses170.8 M162.7 M47.6 M
Slightly volatile
Research Development84.1 M80.1 M28.5 M
Slightly volatile
Total Operating Expenses170.8 M162.7 M42.3 M
Slightly volatile
Total Other Income Expense Net141.4 M134.7 M24 M
Slightly volatile
Selling General Administrative86.7 M82.6 M19.7 M
Slightly volatile
Non Operating Income Net Other456.4 K434.7 K351.5 K
Very volatile
Interest Income10.3 M9.8 M2.4 M
Slightly volatile
Net Interest Income10.3 M9.8 M2.4 M
Slightly volatile
Reconciled Depreciation1.4 M1.3 M462.3 K
Slightly volatile
Selling And Marketing Expenses1.2 M1.4 M1.5 M
Slightly volatile

Cassava Sciences Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow146.3 M139.3 M73.8 M
Slightly volatile
Depreciation1.4 M1.3 M549.4 K
Slightly volatile
End Period Cash Flow155.3 M147.9 M82.5 M
Slightly volatile
Stock Based Compensation19.7 M18.7 M5.8 M
Slightly volatile
Dividends Paid68.6 M77.1 M84.2 M
Slightly volatile
Change Receivables5.7 M6.4 M7 M
Slightly volatile
Change To Netincome2.6 M1.9 M3.2 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio0.830.875.6164
Slightly volatile
Dividend Yield2.212.231.9792
Slightly volatile
PTB Ratio0.820.867.3094
Slightly volatile
Days Sales Outstanding145178157
Pretty Stable
Book Value Per Share3.443.623.7676
Very volatile
Average Payables1.8 M2 M2.2 M
Slightly volatile
Stock Based Compensation To Revenue0.08240.08670.7449
Slightly volatile
Capex To Depreciation0.07780.08196.6894
Very volatile
PB Ratio0.820.867.3094
Slightly volatile
Sales General And Administrative To Revenue0.130.140.2283
Slightly volatile
Research And Ddevelopement To Revenue0.130.146.0642
Slightly volatile
Capex To Revenue0.04360.03830.0359
Pretty Stable
Cash Per Share3.033.194.5535
Slightly volatile
Intangibles To Total Assets3.0E-43.0E-40.0031
Slightly volatile
Current Ratio15.510.4621.9576
Pretty Stable
Tangible Book Value Per Share3.443.623.7648
Very volatile
Receivables Turnover2.72.132.3519
Slightly volatile
Shareholders Equity Per Share3.443.623.7676
Very volatile
Debt To Equity7.0E-47.0E-40.0028
Slightly volatile
Capex Per Share0.00240.00260.0769
Pretty Stable
Graham Net Net2.772.923.4723
Pretty Stable
Revenue Per Share5.127.355.4569
Slightly volatile
Interest Debt Per Share0.00710.0040.0053
Very volatile
Debt To Assets6.0E-47.0E-40.0027
Slightly volatile
Graham Number22.2625.9227.521
Very volatile
Operating Cycle145178157
Pretty Stable
Price Book Value Ratio0.820.867.3094
Slightly volatile
Ebt Per Ebit0.170.150.7887
Slightly volatile
Company Equity Multiplier1.691.241.3645
Slightly volatile
Long Term Debt To Capitalization2.0E-42.0E-40.0017
Slightly volatile
Total Debt To Capitalization7.0E-47.0E-40.0028
Slightly volatile
Debt Equity Ratio7.0E-47.0E-40.0028
Slightly volatile
Quick Ratio15.510.4621.9576
Pretty Stable
Net Income Per E B T1.011.050.95
Pretty Stable
Cash Ratio13.379.8521.3307
Pretty Stable
Days Of Sales Outstanding145178157
Pretty Stable
Free Cash Flow Operating Cash Flow Ratio0.820.91.0782
Very volatile
Price To Book Ratio0.820.867.3094
Slightly volatile
Fixed Asset Turnover88.9584.7287.739
Slightly volatile
Debt Ratio6.0E-47.0E-40.0027
Slightly volatile
Price Sales Ratio0.830.875.6164
Slightly volatile
Asset Turnover0.780.740.6869
Slightly volatile
Gross Profit Margin0.80.90.9821
Slightly volatile
Price Fair Value0.820.867.3094
Slightly volatile

Cassava Sciences Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap27.8 M29.2 M78.5 M
Slightly volatile

Cassava Fundamental Market Drivers

Forward Price Earnings151.5152
Cash And Short Term Investments128.6 M

Cassava Upcoming Events

27th of February 2024
Upcoming Quarterly Report
View
6th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
27th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Cassava Sciences Financial Statements

Cassava Sciences stakeholders use historical fundamental indicators, such as Cassava Sciences' revenue or net income, to determine how well the company is positioned to perform in the future. Although Cassava Sciences investors may analyze each financial statement separately, they are all interrelated. For example, changes in Cassava Sciences' assets and liabilities are reflected in the revenues and expenses on Cassava Sciences' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Cassava Sciences. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue4.2 M4 M
Cost Of Revenue1.3 M1.2 M
Stock Based Compensation To Revenue 0.09  0.08 
Sales General And Administrative To Revenue 0.14  0.13 
Research And Ddevelopement To Revenue 0.14  0.13 
Capex To Revenue 0.04  0.04 
Revenue Per Share 7.35  5.12 
Ebit Per Revenue 0.88  0.83 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
GOOGAlphabet Inc Class C
VVisa Class A
MSFTMicrosoft
When determining whether Cassava Sciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Cassava Sciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Cassava Sciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Cassava Sciences Stock:
How To Invest In Cassava
Details
Is Cassava Stock a good investment?
Details
What is Cassava Sciences' Net Worth?
Details
Largest Pharmaceuticals Companies
View
Largest Pharmaceuticals, Biotechnology & Life Sciences Companies
View
Check out the analysis of Cassava Sciences Correlation against competitors.
For information on how to trade Cassava Stock refer to our How to Trade Cassava Stock guide.
You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cassava Sciences. If investors know Cassava will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cassava Sciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.22)
Return On Assets
(0.30)
Return On Equity
(0.89)
The market value of Cassava Sciences is measured differently than its book value, which is the value of Cassava that is recorded on the company's balance sheet. Investors also form their own opinion of Cassava Sciences' value that differs from its market value or its book value, called intrinsic value, which is Cassava Sciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cassava Sciences' market value can be influenced by many factors that don't directly affect Cassava Sciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Altman
Z Score
Details
Piotroski
F Score
Details
Beneish
M Score
Details
Financial
Analysis
Details
Buy or Sell
Advice
Details
Earnings
Projections
Details
Please note, there is a significant difference between Cassava Sciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Cassava Sciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cassava Sciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY